This study explores new insights into the possible regulatory effect of the dual PI3K/mTOR inhibitor such as PQR309 on the positive feedback loop of PI3K/Akt/mTOR/c-Myc/mtp53 and the role of this loop in endometrial cancer cell proliferation. Here, PIK3CA is linked to endometrial cancer.